Publication:
Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients with Upper Tract Urothelial Carcinoma

dc.contributor.authorMilojevic, Bogomir (36990126400)
dc.contributor.authorDzamic, Zoran (6506981365)
dc.contributor.authorKajmakovic, Boris (56549005500)
dc.contributor.authorDurutovic, Otas (6506011266)
dc.contributor.authorBumbasirevic, Uros (36990205400)
dc.contributor.authorSipetic Grujicic, Sandra (6701802171)
dc.date.accessioned2025-06-12T19:19:59Z
dc.date.available2025-06-12T19:19:59Z
dc.date.issued2015
dc.description.abstractBackground: To investigate the prognostic impact of preoperative anemia on urothelial and extraurothelial recurrence after radical nephroureterectomy. Methods: A single-center series of 238 consecutive patients who were treated with radical nephroureterectomy for upper tract urothelial carcinoma was evaluated. We categorized patients on the basis of hemoglobin level into 2 groups, including normal or anemia. Survival was estimated using the Kaplan-Meier method. Cox proportional hazard regression models were used to evaluate the association of preoperative anemia with outcome, controlling for clinicopathologic variables. Results: Ninety-seven patients (40.8%) had anemia (median hemoglobin level, 143 vs. 107 g/L). Preoperative anemia was associated with history of bladder cancer (P =.01), tumor multifocality (P =.03), lymphovascular invasion (P =.05), and adjuvant chemotherapy (P =.01). Higher tumor stage and grade, and lymph node metastasis were significantly associated with preoperative anemia. Preoperative anemia was independently associated with extraurothelial recurrence (hazard ratio, 1.95; 95% confidence interval, 1.14-3.34; P =.01) in multivariate Cox regression analyses. Only a history of bladder tumor (hazard ratio, 2.07; P =.009) and tumor multifocality (hazard ratio, 3.97; 95% confidence interval, 2.37-6.67; P <.001) were independently associated with urothelial recurrence. The 5-year cancer-specific survival for patients with normal hemoglobin level was 82.1% and for patients with preoperative anemia was 54.2%. Conclusion: Patients with preoperative anemia had a greater probability of having upper tract urothelial carcinoma with higher tumor stages, higher tumor grades, and lymph node metastasis (pN+). Preoperative anemia was statistically significantly associated with worse cancer-specific survival and extraurothelial recurrence in patients who underwent radical nephroureterectomy. © 2015 Elsevier Inc. All rights reserved.
dc.identifier.urihttps://doi.org/10.1016/j.clgc.2015.03.007
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84941599936&doi=10.1016%2fj.clgc.2015.03.007&partnerID=40&md5=76b0f1120e4f1ec5554b7e31449d5566
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/8081
dc.subjectAnemia
dc.subjectRadical nephroureterectomy
dc.subjectRecurrence
dc.subjectSurvival
dc.subjectUpper urinary tract urothelial carcinoma
dc.titlePrognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients with Upper Tract Urothelial Carcinoma
dspace.entity.typePublication

Files